News & Updates
Filter by Specialty:
First-line cabozantinib-atezolizumab boosts PFS in advanced HCC
The combination of cabozantinib and atezolizumab in the first-line setting significantly improved progression-free survival (PFS) compared with sorafenib in patients with advanced hepatocellular carcinoma (HCC), according to results of the phase III COSMIC-312 trial presented at ESMO Asia 2021.
First-line cabozantinib-atezolizumab boosts PFS in advanced HCC
06 Jan 2022
Chronic constipation patients unhappy with conventional treatments: survey
Conventional treatment options for chronic constipation (CC) are not effective enough to improve symptoms or satisfaction among patients, results of an internet survey in Japan have shown.
Chronic constipation patients unhappy with conventional treatments: survey
06 Jan 2022
Electroacupuncture outperforms transcutaneous electrical stimulation in severe constipation
Administering acupuncture with a zap to patients with severe chronic constipation produces better outcomes than transcutaneous electrical stimulation, increasing the frequency of complete spontaneous bowel movements and improving quality of life, as shown in a study.
